Armatus Bio Receives $3M Investment from SOLVE FSHD
Here’s the information extracted from the provided content about Armatus Bio:
Company Information
- Startup: Armatus Bio
- Founders: Not specified in the provided content.
- Location: Columbus, OH
- Industry: Biotechnology (developing vectorized RNAi therapeutics for neuromuscular diseases)
Fundraising Details
- Investors: SOLVE FSHD
- Fundraising Amount: $3M
- Funding Series: Not specifically mentioned (likely a seed or early stage)
- Date of Fundraising: June 5, 2025
Project Details
- Project: ARM-201 (AAV-delivered microRNA therapy)
- Purpose: Designed to silence the expression of DUX4, the toxic protein associated with muscle degeneration in FSHD (Facioscapulohumeral muscular dystrophy).
If you need more detailed information or additional context, let me know!
Source link
2025-05-06 15:52:22
Leave a Reply
You must be logged in to post a comment.